JAN 03, 2021 3:31 PM PST

How Psychedelic Salvinorin A Works in the Brain

WRITTEN BY: Annie Lennon

Despite increasing interest in hallucinogens, the effects of Salvinorin A, a drug used in Native Mexican rituals, have remained unknown. Now, however, researchers from Johns Hopkins University have conducted research on the drug's strength and general effects. 

Salvinorin A is a compound found in a plant called Salvia divinorum and is considered a dissociative hallucinogen. It produces out-of-body and amnesia-like experiences lasting up to 30 minutes. 

For the study, the researchers recruited 12 men aged between 23 and 52. Each was examined via functional magnetic resonance imaging (fMRI) on two occasions- one in which they inhaled Salvinarin A crystals (15 µg/kg), and another in which they inhaled a placebo. 

Altogether, the researchers examined activity in eight brain networks. Three were involved in vision, and five were for moving and touch, paying attention, and activating the default mode network while the mind rests. 

All in all, the researchers found that the default mode network decreased in synchronization, meaning signals in this area became more random and unpredictable. They also observed increased communication between brain networks while on the drug in comparison to the placebo.  

While participants generally reported their experiences to peak in intensity at 2 minutes in, they reported them to drop by approximately a half within 10 minutes. At 45 minutes, the experience had practically finished. 

"Salvinorin A seems to do all the things that researchers believe happen when other psychedelics (such as LSD and psilocybin) act on the brain," says Manoj Doss, Ph.D. one of the study's authors.

"The funny thing is that some researchers have selectively focused on the default mode network when that's not even where they find the strongest effects of classic psychedelics. In contrast, that is, in fact, where we found the strongest effects of salvinorin A."

The researchers now hope to compare their findings with brain imaging studies on other hallucinogenic drugs.

 

Sources: Neuroscience NewsNature

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 27, 2020
Drug Discovery & Development
Attacking Mitochondria in Tumors
DEC 27, 2020
Attacking Mitochondria in Tumors
Researchers found that attacking a cell’s mitochondria can starve cancer cells. The study involves a possible ther ...
JAN 16, 2021
Drug Discovery & Development
Scientists Discover Contents of an Ancient Mayan Drug Containers
JAN 16, 2021
Scientists Discover Contents of an Ancient Mayan Drug Containers
Washington State University researchers found a non-tobacco plant in containers of an ancient Maya drug. "While it ...
JAN 28, 2021
Immunology
Killers With a Hit on the Spike
JAN 28, 2021
Killers With a Hit on the Spike
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e ...
FEB 10, 2021
Drug Discovery & Development
Genetics Affect Response to Cancer Immunotherapy
FEB 10, 2021
Genetics Affect Response to Cancer Immunotherapy
Researchers have found that genetic factors may dictate as much as 20% of the efficacy of checkpoint inhibitors, a kind ...
FEB 20, 2021
Drug Discovery & Development
Deep Brain Stimulation Offsets Epileptic Seizures
FEB 20, 2021
Deep Brain Stimulation Offsets Epileptic Seizures
Researchers from the University of Freiburg in Germany have found that deep brain stimulation (DBS) in the brain’s ...
MAR 05, 2021
Drug Discovery & Development
Personalized Treatment for Sickle Cell Disease
MAR 05, 2021
Personalized Treatment for Sickle Cell Disease
Globally, the most prevalent inherited blood disease is sickle cell which affects 70,000 to 100,000 Americans. Despite s ...
Loading Comments...